Pharmacological fMRI provides evidence for opioidergic modulation of discrimination of facial pain expressions

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Article numbere13717
Number of pages17
JournalPsychophysiology
Volume58
Issue number2
Early online date3 Nov 2020
DOIs
Publication statusPublished - Feb 2021

Funding

This work was supported by Chinese Scholarship Council (CSC) Grant #201604910515 to Y.Z.; the Vienna Science and Technology Fund (WWTF VRG13‐007) and the Austrian Science Fund (FWF P 32686) to C.L. We thank Elena Navratil, Kathrin Steinmüller and Pablo Reinhardt for help with data acquisition.

Austrian Fields of Science 2012

  • 501014 Neuropsychology
  • 301210 Psychopharmacology

Keywords

  • emotion discrimination
  • facial expression
  • fMRI
  • naltrexone
  • opioid system
  • pain
  • psychopharmacology
  • right fusiform face area
  • ATTENTION
  • RECOGNITION
  • FUSIFORM FACE AREA
  • PLACEBO ANALGESIA
  • NETWORKS
  • IDENTITY
  • PERCEPTION
  • RESPONSES
  • NALTREXONE
  • EMPATHY

Fingerprint

Dive into the research topics of 'Pharmacological fMRI provides evidence for opioidergic modulation of discrimination of facial pain expressions'. Together they form a unique fingerprint.

Cite this